Remed Co.,Ltd. (KOSDAQ:302550)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,090.00
+5.00 (0.16%)
At close: Apr 28, 2026

Remed Revenue

In the year 2025, Remed had annual revenue of 24.50B KRW, down -4.11%. Remed had revenue of 6.70B in the quarter ending December 31, 2025, with 3.86% growth.

Revenue
24.50B
Revenue Growth
-4.11%
P/S Ratio
3.90
Revenue / Employee
266.36M
Employees
92
Market Cap
95.50B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202524.50B-1.05B-4.11%
Dec 31, 202425.55B7.02B37.86%
Dec 31, 202318.54B-2.83B-13.23%
Dec 31, 202221.36B1.17B5.79%
Dec 31, 202120.20B3.56B21.42%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Neofect 16.05B
Noul Co.,Ltd. 5.12B
SELVAS Healthcare 30.82B
QuantaMatrix 3.69B
Hironic 32.09B
JPI Healthcare 48.47B
DRGEM 102.75B
Genoray 108.04B
Revenue Rankings